135 related articles for article (PubMed ID: 17663001)
21. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer.
Yang DC; Wang F; Elliott RL; Head JF
Anticancer Res; 2001; 21(1B):541-9. PubMed ID: 11299801
[TBL] [Abstract][Full Text] [Related]
22. Prolactin as a local growth promoter in patients with breast cancer: GCRI experience.
Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Ghosh N; Chikhlikar PR; Trivedi TI
Eur J Surg Oncol; 2000 Sep; 26(6):540-7. PubMed ID: 11034803
[TBL] [Abstract][Full Text] [Related]
23. The clinical significance of MMP-1 expression in oesophageal carcinoma.
Yamashita K; Mori M; Kataoka A; Inoue H; Sugimachi K
Br J Cancer; 2001 Jan; 84(2):276-82. PubMed ID: 11161388
[TBL] [Abstract][Full Text] [Related]
24. DPD activity and immunohistochemical DPD expression in human breast cancer.
Horiguchi J; Yoshida T; Koibuchi Y; Iijima K; Ninomiya J; Takei H; Yokoe T; Iino Y; Morishita Y
Oncol Rep; 2004 Jan; 11(1):65-72. PubMed ID: 14654904
[TBL] [Abstract][Full Text] [Related]
25. Tissue and serum metalloproteinase (MMP-2) expression in advanced ovarian serous cystoadenocarcinomas: clinical and prognostic implications.
Garzetti GG; Ciavattini A; Lucarini G; Goteri G; de e Nictolis M; Garbisa S; Masiero L; Romanini C; Graziella B
Anticancer Res; 1995; 15(6B):2799-804. PubMed ID: 8669868
[TBL] [Abstract][Full Text] [Related]
26. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer.
Takeuchi T; Hisanaga M; Nagao M; Ikeda N; Fujii H; Koyama F; Mukogawa T; Matsumoto H; Kondo S; Takahashi C; Noda M; Nakajima Y
Clin Cancer Res; 2004 Aug; 10(16):5572-9. PubMed ID: 15328199
[TBL] [Abstract][Full Text] [Related]
27. Expression of interleukin-6, interleukin-6 receptor, and glycoprotein 130 correlates with good prognoses for patients with breast carcinoma.
Karczewska A; Nawrocki S; Breborowicz D; Filas V; Mackiewicz A
Cancer; 2000 May; 88(9):2061-71. PubMed ID: 10813718
[TBL] [Abstract][Full Text] [Related]
28. High expression of steroid sulfatase mRNA predicts poor prognosis in patients with estrogen receptor-positive breast cancer.
Miyoshi Y; Ando A; Hasegawa S; Ishitobi M; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2003 Jun; 9(6):2288-93. PubMed ID: 12796397
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer.
Sasaki H; Yukiue H; Moiriyama S; Kobayashi Y; Nakashima Y; Kaji M; Kiriyama M; Fukai I; Yamakawa Y; Fujii Y
J Surg Res; 2001 Dec; 101(2):242-7. PubMed ID: 11735282
[TBL] [Abstract][Full Text] [Related]
30. Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast.
Zhang Z; Yamashita H; Toyama T; Omoto Y; Sugiura H; Hara Y; Wu X; Kobayashi S; Iwase H
Breast Cancer Res; 2003; 5(6):R250-6. PubMed ID: 14580261
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in bladder carcinoma.
Xu K; Hou S; Du Z
Chin Med J (Engl); 2002 May; 115(5):743-5. PubMed ID: 12133547
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of uPA, PAI-1 and PAI-2 mRNA expression in primary breast cancer.
Spyratos F; Bouchet C; Tozlu S; Labroquere M; Vignaud S; Becette V; Lidereau R; Bieche I
Anticancer Res; 2002; 22(5):2997-3003. PubMed ID: 12530032
[TBL] [Abstract][Full Text] [Related]
33. Allelic loss at the 8p22 region as a prognostic factor in large and estrogen receptor negative breast carcinomas.
Utada Y; Haga S; Kajiwara T; Kasumi F; Sakamoto G; Nakamura Y; Emi M
Cancer; 2000 Mar; 88(6):1410-6. PubMed ID: 10717624
[TBL] [Abstract][Full Text] [Related]
34. Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer.
Emberley ED; Niu Y; Njue C; Kliewer EV; Murphy LC; Watson PH
Clin Cancer Res; 2003 Jul; 9(7):2627-31. PubMed ID: 12855640
[TBL] [Abstract][Full Text] [Related]
35. E-cadherin mRNA expression in breast carcinomas correlates with overall and disease-free survival.
Guriec N; Marcellin L; Gairard B; Caldéroli H; Wilk A; Renaud R; Bergerat JP; Oberling F
Invasion Metastasis; 1996; 16(1):19-26. PubMed ID: 8830762
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of ERM gene expression in human primary breast cancers.
Chotteau-Lelièvre A; Révillion F; Lhotellier V; Hornez L; Desbiens X; Cabaret V; de Launoit Y; Peyrat JP
Clin Cancer Res; 2004 Nov; 10(21):7297-303. PubMed ID: 15534105
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma.
Yamashita K; Mori M; Shiraishi T; Shibuta K; Sugimachi K
Clin Cancer Res; 2000 Mar; 6(3):1169-74. PubMed ID: 10741748
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of matrix metalloproteinase-1 and -9 mRNA is associated with progression of oral dysplasia to cancer.
Jordan RC; Macabeo-Ong M; Shiboski CH; Dekker N; Ginzinger DG; Wong DT; Schmidt BL
Clin Cancer Res; 2004 Oct; 10(19):6460-5. PubMed ID: 15475433
[TBL] [Abstract][Full Text] [Related]
39. Tumor cell specific expression of MMP-2 correlates with tumor vascularisation in breast cancer.
Djonov V; Cresto N; Aebersold DM; Burri PH; Altermatt HJ; Hristic M; Berclaz G; Ziemiecki A; Andres AC
Int J Oncol; 2002 Jul; 21(1):25-30. PubMed ID: 12063545
[TBL] [Abstract][Full Text] [Related]
40. Insulin-like growth factor (IGF)-system mRNA quantities in normal and tumor breast tissue of women with sporadic and familial breast cancer risk.
Voskuil DW; Bosma A; Vrieling A; Rookus MA; van 't Veer LJ
Breast Cancer Res Treat; 2004 Apr; 84(3):225-33. PubMed ID: 15026620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
